apollo
logo
0Login
Introducing Our Latest Arrival!
Bilypsa Tablet 45's

Bilypsa Tablet 45's

Consult Doctor
Prescription drug
 Trailing icon

Composition

SAROGLITAZAR-4MG

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

About Bilypsa Tablet 45's

Bilypsa Tablet 45's is an insulin sensitiser used to treat diabetic dyslipidaemia/hypertriglyceridemia in type-2 diabetic patients, which is not controlled by statins (lipid-lowering agents) alone. Bilypsa Tablet 45's has both lipid and glucose-lowering effects in a single molecule; thereby, helps lower blood triglycerides and blood glucose levels. Diabetic dyslipidaemia is characterised by increased triglyceride levels, low-density lipoproteins (LDL) and decreased high-density lipoprotein (HDL) levels. This condition is common in people with type-2 diabetes mellitus.
 
Bilypsa Tablet 45's contains ‘Saroglitazar’, which has dual Peroxisome Proliferator-Activated Receptor (PPAR)-α/γ agonist having strong PPAR-alpha effect and moderate PPAR-gamma effect. PPAR-alpha reduces the synthesis and secretion of triglycerides, increases lipolysis and hepatic oxidation of fatty acids. It also induces an increase in the synthesis of HDL cholesterol. PPAR-gamma reduces the metabolic burden on the liver, muscle and promotes glucose utilisation. It improves post-absorptive insulin-mediated suppression of hepatic glucose output. Thereby, Bilypsa Tablet 45's helps in lowering blood triglycerides and blood glucose levels.
 
You are advised to take Bilypsa Tablet 45's for as long as your doctor has prescribed it, depending on your medical condition. In some cases, you may experience certain common side effects such as stomach inflammation, nausea, vomiting, weakness, chest discomfort, dizziness, and fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are recommended to consult your doctor if you experience these side effects persistently.
 
Consult your doctor if you are pregnant. It is not known if Bilypsa Tablet 45's is excreted into breastmilk; therefore, nursing mothers should avoid taking Bilypsa Tablet 45's. Bilypsa Tablet 45's should not be given to children as safety and effectiveness have not been established. Bilypsa Tablet 45's should be used with caution in patients with kidney or liver impairment and in elderly patients. Avoid alcohol consumption while taking Bilypsa Tablet 45's as it might cause unpleasant side-effects. Bilypsa Tablet 45's might cause dizziness, so drive with caution. Inform your doctor about all the medications you are taking and your health condition to rule out any unpleasant side effects.

Uses of Bilypsa Tablet 45's

Diabetic dyslipidaemia/hypertriglyceridemia

Medicinal Benefits

Bilypsa Tablet 45's is an insulin sensitiser used to treat diabetic dyslipidaemia/hypertriglyceridemia in type-2 diabetes, which is not controlled by statins alone. Bilypsa Tablet 45's has demonstrated reduction of triglycerides (TG), Low-Density Lipoprotein (LDL) cholesterol, non-High-Density Lipoprotein (non- HDL) cholesterol, Very Low-Density Lipoprotein (VLDL) cholesterol, and an increase in HDL cholesterol. It has also shown glycemic indices by lowering the fasting plasma glucose and glycosylated haemoglobin in diabetic patients. Bilypsa Tablet 45's has dual Peroxisome Proliferator-Activated Receptor (PPAR)-α/γ agonist having strong PPAR-alpha effect and moderate PPAR-gamma effect. PPAR-alpha reduces the synthesis and secretion of triglycerides, increases lipolysis and hepatic oxidation of fatty acids. It also induces an increase in the synthesis of HDL cholesterol. PPAR-gamma reduces the metabolic burden on the liver, muscle and promotes glucose utilisation, and improves post-absorptive insulin-mediated suppression of hepatic glucose output. Bilypsa Tablet 45's has both lipid and glucose-lowering effects in a single molecule; this helps in lowering blood triglycerides and blood glucose levels as well. It also helps in improving insulin resistance. Bilypsa Tablet 45's offers a superior safety profile, greater efficacy on lipid regulation, and excellent glycaemic control.

Directions for Use

Swallow Bilypsa Tablet 45's as a whole with a glass of water; do not break or chew it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Bilypsa Tablet 45's

  • Gastritis (stomach inflammation)
  • Nausea
  • Vomiting
  • Asthenia (weakness)
  • Chest discomfort
  • Dizziness
  • Pyrexia (fever)

Drug Warnings

Do not take Bilypsa Tablet 45's if you are allergic to any of the components. Inform your doctor if you notice rapid weight gain. Consult your doctor before taking Bilypsa Tablet 45's if you are pregnant. It is not known if Bilypsa Tablet 45's is excreted into breastmilk; therefore, nursing mothers should avoid taking Bilypsa Tablet 45's. Bilypsa Tablet 45's should not be given to children as safety and effectiveness have not been established. Bilypsa Tablet 45's might cause dizziness, so drive with caution. Avoid alcohol consumption while taking Bilypsa Tablet 45's as it might cause unpleasant side-effects. Bilypsa Tablet 45's should be used with caution in patients with type-2 diabetes having cardiovascular disease.

Drug Interactions

Drug-Drug Interactions: No interactions found/established.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: No interactions found/established.

Habit Forming

No

Diet & Lifestyle Advise

  • Follow a cholesterol-lowering diet.
  • Exercise regularly. It helps in maintaining proper weight and lowers cholesterol.
  • Limit salt and sugar intake.
  • Avoid smoking and alcohol consumption. 
  • Choose healthy fats and cut down on trans-fat.
  • Include omega-3 fatty acids, fibre-rich food, fruits and vegetables.
  • Get active by doing any physical activity such as swimming, brisk walking or jogging. Take stairs instead of elevators/lifts.
  • Try eating food at regular intervals. Do not skip meals. Also, try not to overeat.
  • Follow a healthy diet and walk for at least 45 minutes to complement treatment with Bilypsa Tablet 45's.
  • Rest properly, avoid stress by doing meditation or yoga.

Disease/Condition Glossary

Diabetic dyslipidaemia/hypertriglyceridemia: Diabetic dyslipidaemia, also known as hypertriglyceridemia, is characterised by increased triglyceride levels, low-density lipoproteins (LDL) and decreased high-density lipoprotein (HDL) levels. This condition is common in people with type-2 diabetes mellitus. It is one of the major risk factors for cardiovascular disease in diabetic patients. Lifestyle, genetics, obesity, consumption of high saturated/trans fat, low thyroid levels, and kidney disease could be the cause of dyslipidaemia. Symptoms of diabetic dyslipidaemia include chest pain/tightness, indigestion, heartburn, dizziness, palpitations, shortness of breath, cold sweats, nausea, and vomiting.

Country of origin

India

Manufacturer/Marketer address

Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Other Info - BIL0060

FAQs

Bilypsa Tablet 45's decreases triglycerides, LDL cholesterol and increases HDL cholesterol. It also helps in promoting glucose utilisation. Thereby, Bilypsa Tablet 45's improves insulin resistance, and lowers blood triglycerides and blood glucose levels.
Bilypsa Tablet 45's does not cause weight gain or oedema. However, inform your doctor if you notice rapid weight gain. Your doctor might assess you for fluid accumulation, volume-related events such as oedema and congestive heart failure.
Do not stop taking Bilypsa Tablet 45's without consulting your doctor. To treat your condition effectually, continue taking Bilypsa Tablet 45's for as long as your doctor has prescribed it.
Bilypsa Tablet 45's can be taken by elderly patients if prescribed by the doctor. However, Bilypsa Tablet 45's should be used with caution in geriatric patients.
Consult your doctor before taking Bilypsa Tablet 45's if you have cardiac problems. If prescribed, Bilypsa Tablet 45's should be used with caution in patients with type-2 diabetes having heart-related problems with episodic congestive heart failure. Regular monitoring for signs and symptoms of congestive heart failure in such patients is advised.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

You are recommended to avoid alcohol consumption while taking Bilypsa Tablet 45's to prevent unpleasant side effects.

bannner image

Pregnancy

Caution

Bilypsa Tablet 45's belongs to pregnancy category C. Consult your doctor before taking Bilypsa Tablet 45's if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Breast Feeding

Unsafe

Nursing mothers should avoid taking Bilypsa Tablet 45's as it is not known if Bilypsa Tablet 45's is excreted into breastmilk.

bannner image

Driving

Caution

Bilypsa Tablet 45's may cause dizziness. Therefore, drive or operate machinery only if you are alert.

bannner image

Liver

Caution

Bilypsa Tablet 45's should be used with caution in patients with liver disease. Please consult your doctor if you have a liver impairment or any concerns regarding this.

bannner image

Kidney

Caution

Bilypsa Tablet 45's should be used with caution in patients with kidney disease. Please consult your doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Unsafe

Bilypsa Tablet 45's is not recommended for children as the safety and effectiveness have not been established.

Add to Cart